ABO blood type does not influence the risk of cardiovascular complications and mortality after vascular surgery

European Journal of Vascular and Endovascular Surgery

Volumn 45, Issue 3, 2013, Pages 256-260

  Bakker, E J ^a   Valentijn, T M ^a   Hoeks, S E ^a   Van De Luijtgaarden, K M ^a   Leebeek, F W ^a   Verhagen, H J M ^a   Stolker, R J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ABO blood group system; Cardiovascular complications; Mortality; Vascular surgical procedures

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ARTERY SURGERY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DESCENDING AORTA SURGERY; DRUG USE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GENDER; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SMOKING; VASCULAR SURGERY;

ABO BLOOD-GROUP SYSTEM; AGED; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 84874527277     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2012.11.022     Document Type: Article

References (30)

1. J.P. van Kuijk, W.J. Flu, G.M. Welten, S.E. Hoeks, M. Chonchol, and R. Vidakovic Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease Eur Heart J 31 2010 992 999
2. N.R. Hertzer, E.G. Beven, J.R. Young, P.J. O'Hara, W.F. Ruschhaupt 3rd, and R.A. Graor Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management Ann Surg 199 1984 223 233
3. G.M. Welten, O. Schouten, S.E. Hoeks, M. Chonchol, R. Vidakovic, and R.T. van Domburg Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease J Am Coll Cardiol 51 2008 1588 1596
4. M.R. Back, F. Leo, D. Cuthbertson, B.L. Johnson, M.L. Shamesmd, and D.F. Bandyk Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation J Vasc Surg 40 2004 752 760
5. M.M. Dawood, D.K. Gutpa, J. Southern, A. Walia, J.B. Atkinson, and K.A. Eagle Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention Int J Cardiol 57 1996 37 44
6. O. Wu, N. Bayoumi, M.A. Vickers, and P. Clark ABO(H) blood groups and vascular disease: a systematic review and meta-analysis J Thromb Haemost 6 2008 62 69
7. B. Bronte-Stewart, M.C. Botha, and L.H. Krut ABO blood groups in relation to ischaemic heart disease Br Med J 1 1962 1646 1650
8. K.J. Kingsbury Relation of ABO blood-groups to atherosclerosis Lancet 1 1971 199 203
9. D.A. Ionescu, I. Marcu, and E. Bicescu Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups Lancet 1 1976 278 280
10. S. Talbot, E.J. Wakley, D. Ryrie, and M.J. Langman ABO blood groups and venous thromboembolic disease Lancet 1 1970 1257 1259
11. J.C. Souto, L. Almasy, E. Muniz-Diaz, J.M. Soria, M. Borrell, and L. Bayen Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time Arterioscler Thromb Vasc Biol 20 2000 2024 2028
12. C. Denis, D. Baruch, C.M. Kielty, N. Ajzenberg, O. Christophe, and D. Meyer Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen Arterioscler Thromb 13 1993 398 406
13. E.G. Tuddenham, R.S. Lane, F. Rotblat, A.J. Johnson, T.J. Snape, and S. Middleton Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease Br J Haematol 52 1982 259 267
14. T. Koster, A.D. Blann, E. Briet, J.P. Vandenbroucke, and F.R. Rosendaal Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 345 1995 152 155
15. A.Y. Nossent, V. van Marion, N.H. van Tilburg, F.R. Rosendaal, R.M. Bertina, and J.A. van Mourik von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis J Thromb Haemost 4 2006 2556 2562
16. R.A. Kraaijenhagen, P.S. in't Anker, M.M. Koopman, P.H. Reitsma, M.H. Prins, and A. van den Ende High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism Thromb Haemost 83 2000 5 9
17. R.G. Wieberdink, M.C. van Schie, P.J. Koudstaal, A. Hofman, J.C. Witteman, and M.P. de Maat High von Willebrand factor levels increase the risk of stroke: the Rotterdam study Stroke 41 2010 2151 2156
18. M.C. van Schie, J.E. van Loon, M.P. de Maat, and F.W. Leebeek Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review J Thromb Haemost 9 2011 899 908
19. M. Shima, Y. Fujimura, T. Nishiyama, T. Tsujiuchi, N. Narita, and T. Matsui ABO blood group genotype and plasma von Willebrand factor in normal individuals Vox Sang 68 1995 236 240
20. D.J. Bowen An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13 J Thromb Haemost 1 2003 33 40
21. A.J. Vlot, E.P. Mauser-Bunschoten, A.G. Zarkova, E. Haan, C.L. Kruitwagen, and J.J. Sixma The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A Thromb Haemost 83 2000 65 69
22. D. Poldermans, J.J. Bax, E. Boersma, S. De Hert, E. Eeckhout, and G. Fowkes Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery Eur Heart J 30 2009 2769 2812
23. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
24. T.R. Ketch, S.J. Turner, M.T. Sacrinty, K.C. Lingle, R.J. Applegate, and M.A. Kutcher ABO blood types: influence on infarct size, procedural characteristics and prognosis Thromb Res 123 2008 200 205
25. C. Carpeggiani, M. Coceani, P. Landi, C. Michelassi, and A. L'Abbate ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study Atherosclerosis 211 2010 461 466
26. C. Kearon, J.A. Julian, M.J. Kovacs, D.R. Anderson, P. Wells, and B. Mackinnon Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial Blood 112 2008 4432 4436
27. R.J. Jaumdally, G.Y. Lip, C. Varma, and A.D. Blann Impact of high dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes Angiology 62 2011 571 578
28. I.J. Dahabreh, and D.M. Kent Index event bias as an explanation for the paradoxes of recurrence risk research J Am Med Assoc 305 2011 822 823
29. P.V. Jenkins, and J.S. O'Donnell ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 46 2006 1836 1844
30. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 381S 453S